3 unknown. 3 Phase 1, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 3 | Unknown 3 |
| Phase 2 | 2 | Unknown 2 |
Follow Fasting: new trials by email Literature Review of Fasting trials Research Report on Fasting
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Bioequivalence Study of Sulfadoxine/Pyrimethamine 500/25 mg Dispersible Tablet Sulfadoxine 500 MG / Pyrimethamine 25 MG dispersible tablets., Sulfadoxine 500 MG / Pyrimethamine 25 MG dispersible tablets in SPAQ - Fasting | Phase 1 | Unknown | Swiss Pharma Nigeria Limited | 46 | 2024-07-01 | 2024-07-26 |
| Fighting Immunosenescence and Promoting Immunity by a Fasting-mimicking Diet Elderly. Prolon - FMD - Frailty, Inflammation | Phase 1 / Phase 2 | Unknown | University of Genova | 40 | 2020-09-15 | 2021-10-25 |
| The Effect of Time-restricted Feeding on Physiological Function in Middle-aged and Older Adults Time Restricted Feeding - Aging | Phase 1 / Phase 2 | Unknown | University of Colorado, Boulder | 12 | 2016-04-01 | 2019-06-14 |
Frailty (1) · Immune System Diseases (1) · Inflammation (1) · Intermittent Fasting (1)
Behavior (3) · Feeding Behavior (3) · Pathologic Processes (1) · Pathological Conditions, Signs and Symptoms (1)
Pyrimethamine (1) · Sulfadoxine (1)
Swiss Pharma Nigeria Limited (1) · University of Colorado, Boulder (1) · University of Genova (1)
Italy (1) · Jordan (1) · United States (1)
Christopher R Martens, Ph.D. (1) · Majdi Abu Awida, Doctor (1)